Cached score snapshot
US.HUM · Humana
110分制 54.7/110;5D動能v2 23/50;排序分 77.7/160
Score breakdown
避免
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +0.49% | -2.54% / +3.52% | 57.5% | 5% | Actual -4.11% · vs median -4.60% · inside 25-75 band |
| 30D observation | +2.35% | -6.94% / +9.42% | 62.5% | 27.5% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | -0.29% | -2.60% / +2.83% | 46.3% | 7.5% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-07-02 → 2026-11-06 · 206 archived points · 2 Improving turn signal · 6 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 19.9 · 市場環境 10.8 · 5D動能v2 23
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 2.9/5 · 較差
Sub-items
資金流 — 9.2/20 · 較差
Sub-items
institutional
details
warning
市場環境 — 10.8/15 · 良好
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 5.9/10 · 較差
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 19.9/30 · 一般
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 4/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 2.9/5分 資金流分析總分: 9.2/20分 市場環境分析總分: 10.8/15分 催化劑分析: 2/20分 風險管理總分: 5.9/10分 技術信號分析總分: 19.9/30分 情緒分析: 4/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Elevated",
"reason": "risk management score >= 5/10",
"position": {
"score": 1.3,
"details": {
"atrPct": 3.522504046503255,
"turnoverUsdM": 771.387285615,
"liquidityPoints": 0.6,
"volatilityPoints": 0.7
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.HUM",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 369.8958,
"strength_details": {
"ma_score": 2,
"atr_score": 1,
"rsi_score": 1,
"macd_score": 1,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1,
"stop_loss_percent": 7,
"take_profit_price": 418.8622,
"target_multiplier": 1.6,
"technical_strength": 1.4,
"take_profit_percent": 5.3
},
"positionPoints": 1.3,
"stopLossPoints": 1.2,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 7.04500809300651,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 77.7,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 54.7,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 23
},
"market": {
"ma20": 392.4515,
"ma50": 386.7364,
"close": 397.93,
"prevClose": 380.32,
"avgVolume20": 969940,
"volumeRatio": 2,
"changePercent": 4.63
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 23,
"details": {
"ret_5d": 0.03031948112474736,
"max_score": 50,
"max_total": 50,
"raw_total": 23,
"vcp_bonus": 0,
"vol_ratio": 2.1117017799952067,
"ret_points": 8,
"vol_points": 8,
"range_ratio": 2.203819610495133,
"volat_points": 4,
"day_range_pct": 0.06749936088003827,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 3,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 77.7,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 2.9,
"label": "基本面",
"weight": "5/110",
"normalized": 58,
"contribution": 2.9
},
{
"raw": 9.2,
"label": "資金流",
"weight": "20/110",
"normalized": 46,
"contribution": 9.2
},
{
"raw": 10.8,
"label": "市場環境",
"weight": "15/110",
"normalized": 72,
"contribution": 10.8
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 5.9,
"label": "風險管理",
"weight": "10/110",
"normalized": 59,
"contribution": 5.9
},
{
"raw": 19.9,
"label": "技術信號",
"weight": "30/110",
"normalized": 66.33,
"contribution": 19.9
},
{
"raw": 4,
"label": "情緒分析",
"weight": "10/110",
"normalized": 40,
"contribution": 4
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "避免",
"result": 54.7,
"details": [
"基本面分析總分: 2.9/5分",
"資金流分析總分: 9.2/20分",
"市場環境分析總分: 10.8/15分",
"催化劑分析: 2/20分",
"風險管理總分: 5.9/10分",
"技術信號分析總分: 19.9/30分",
"情緒分析: 4/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 2.9,
"資金流": 9.2,
"市場環境": 10.8,
"情緒分析": 4,
"技術信號": 19.9,
"風險管理": 5.9
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 7,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "較差",
"items": {
"pbPoints": 0.5,
"pePoints": 0.2,
"epsPoints": 0,
"roePoints": 0,
"debtPoints": 0.5,
"marginPoints": 0,
"turnoverUsdM": 771.387285615,
"volumePoints": 0.5,
"revenuePoints": 0.4,
"dividendPoints": 0.3,
"marketCapPoints": 0.5
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 1.6,
"obvPoints": 2.4,
"vwapPoints": 2.4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.HUM",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "良好",
"items": {
"vix": {
"score": 2.4,
"details": {
"source": "twelvedata+fred",
"vixClose": 14.21
}
},
"trend": {
"score": 4,
"details": {
"qqq": {
"ma20": 720.8744953000001,
"ma50": 712.6535974199999,
"name": "QQQ",
"close": 744.5,
"points": 2
},
"spy": {
"ma20": 765.3504968,
"ma50": 761.5657979799997,
"name": "SPY",
"close": 771.34998,
"points": 2
},
"source": "twelvedata+fred"
}
},
"atrPct": 3.522504046503255,
"atrPoints": 2,
"cciPoints": 2.4,
"vixPoints": 2.4,
"marketTrendPoints": 4
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 4,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 7,
"negativeHits": 0,
"positiveHits": 2,
"sentimentScoreRaw": 0.7
}
},
"sentimentData": {
"raw": [
{
"id": 142443091,
"url": "https://finnhub.io/api/news?id=a58edb79880cef55fb168c4221ed3e1d3bf6519e46e8f6db8ccccabf029534ab",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana (HUM) moved sharply higher this week after Barclays shifted its rating on the insurer to Overweight from Equalweight, indicating that the shares could outperform sector peers. At around US$397.93, Humana’s recent 4.63% 1 day share price return and 3.21% 30 day share price return build on a strong year to date share price return of 50.46%. However, the 3 year total shareholder return has declined 15.34%, suggesting the latest upgrade is being read as a fresh shift in sentiment rather...",
"category": "company",
"datetime": 1790474934,
"headline": "Humana (HUM) Jumped, But What Is Drawing Fresh Attention Now?"
},
{
"id": 142432687,
"url": "https://finnhub.io/api/news?id=f0b8a5e6ce06eb93cf3259e023de36cbb273540a60b805a268172c8af0497c7e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Shares of health insurance company Humana (NYSE:HUM) jumped 8% in the afternoon session after Barclays upgraded the stock from Equalweight to Overweight.",
"category": "company",
"datetime": 1790390437,
"headline": "Why Humana (HUM) Stock Is Up Today"
},
{
"id": 142158658,
"url": "https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...",
"category": "company",
"datetime": 1789463559,
"headline": "Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"
},
{
"id": 142029915,
"url": "https://finnhub.io/api/news?id=a3f21a82f91c178faa0f4bc8487cc5be3663f08d7ba39cae1a62306d768a3c3e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train […]",
"category": "company",
"datetime": 1788986449,
"headline": "Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?"
},
{
"id": 141400599,
"url": "https://finnhub.io/api/news?id=9d90d4e5138ac8a98cf320fac328abc928691d6bcb98f4bb3028b0f9bb6de468",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]",
"category": "company",
"datetime": 1788446067,
"headline": "Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?"
},
{
"id": 141363990,
"url": "https://finnhub.io/api/news?id=d8d5bb41fbb758c304ca112e2b71c45105d7af2e7520ac3aa026b2d9a7a21438",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana (HUM) has drawn fresh attention after announcing that Shantanu Nundy, M.D., will become Chief Medical Officer on August 31, 2026, in a move that foregrounds technology, AI and clinical leadership. Humana’s appointment of a technology focused Chief Medical Officer comes as the stock trades at US$383.23. The share price return is up 5.32% over 30 days and 19.43% over 90 days, while the year-to-date share price return of 44.90% contrasts with a 3-year total shareholder return that has...",
"category": "company",
"datetime": 1788271598,
"headline": "Humana (HUM) Names New Medical Chief On AI Push As Valuation Debate Builds"
},
{
"id": 141363993,
"url": "https://finnhub.io/api/news?id=e9fd48aaac9ac9421f4402b744ac94953fe99973db974354eaa0fb5a8da7dbc9",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1787934616,
"headline": "Why Is Humana (HUM) Up 7.1% Since Last Earnings Report?"
}
],
"raw_source": [
{
"id": 142443091,
"url": "https://finnhub.io/api/news?id=a58edb79880cef55fb168c4221ed3e1d3bf6519e46e8f6db8ccccabf029534ab",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana (HUM) moved sharply higher this week after Barclays shifted its rating on the insurer to Overweight from Equalweight, indicating that the shares could outperform sector peers. At around US$397.93, Humana’s recent 4.63% 1 day share price return and 3.21% 30 day share price return build on a strong year to date share price return of 50.46%. However, the 3 year total shareholder return has declined 15.34%, suggesting the latest upgrade is being read as a fresh shift in sentiment rather...",
"category": "company",
"datetime": 1790474934,
"headline": "Humana (HUM) Jumped, But What Is Drawing Fresh Attention Now?"
},
{
"id": 142432687,
"url": "https://finnhub.io/api/news?id=f0b8a5e6ce06eb93cf3259e023de36cbb273540a60b805a268172c8af0497c7e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Shares of health insurance company Humana (NYSE:HUM) jumped 8% in the afternoon session after Barclays upgraded the stock from Equalweight to Overweight.",
"category": "company",
"datetime": 1790390437,
"headline": "Why Humana (HUM) Stock Is Up Today"
},
{
"id": 142425534,
"url": "https://finnhub.io/api/news?id=497c05dbdd185b5daee0e5704ea3d188104bc74edbd1c42af5529f74a5fd3b55",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index increasing 0.3% and the",
"category": "company",
"datetime": 1790365811,
"headline": "Sector Update: Healthcare Stocks Higher Late Afternoon"
},
{
"id": 142425310,
"url": "https://finnhub.io/api/news?id=b26709e0a9895e9dabe9e7d0cd4238a29c761ebd827ec7d7cdc10dcfa2dff969",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "HUM",
"summary": "Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
"category": "company",
"datetime": 1790363101,
"headline": "Top S&P500 movers in Friday's session"
},
{
"id": 142425635,
"url": "https://finnhub.io/api/news?id=cc4bdd8652f900fee558578f88668f84196a101998a77f33f53b723da84b8379",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Investing.com -- Humana Inc. (NYSE:HUM) shares rose 6% Friday after Barclays upgraded the health insurer to overweight from equal-weight ahead of the upcoming Medicare Star ratings release.",
"category": "company",
"datetime": 1790362782,
"headline": "Humana surges: Barclays bets big on Medicare star ratings rebound"
},
{
"id": 142425122,
"url": "https://finnhub.io/api/news?id=0d41d472a3c61877a78173ca1812c78e13c4a7ab5ff1180522c81f12f81fe3e9",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Barclays just broke its silence on Humana with a conviction call that sent shares surging well past anything the broader health care sector is doing today, raising the question of whether this upgrade signals the start of something bigger or a rally built on a single opinion.",
"category": "company",
"datetime": 1790359149,
"headline": "Humana Jumps 7% on Barclays Upgrade and $515 Target; UnitedHealth Nudges Higher"
},
{
"id": 142424342,
"url": "https://finnhub.io/api/news?id=934105b468350b5d32bbeacccbde6d0bf0f602402f2458bf63ad1cd8b5c90e5c",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "HUM",
"summary": "Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.",
"category": "company",
"datetime": 1790354101,
"headline": "Discover which S&P500 stocks are making waves on Friday."
},
{
"id": 142424936,
"url": "https://finnhub.io/api/news?id=de2a50debecd5a9b78bc22b537fe263eaaee9cb722d5f42e9eb2154e7d9c7d13",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Barclays upgraded Humana stock to Overweight from Neutral and raised its price target to $515 from $407.",
"category": "company",
"datetime": 1790352540,
"headline": "Humana Stock Jumps. Why It Could Be a Big Winner in Next Medicare Star Ratings."
},
{
"id": 142437401,
"url": "https://finnhub.io/api/news?id=ad0db2f0cba0ca406add338bdd82f007e8b4746106bec86a39fae04943436d63",
"image": "https://cdn.benzinga.com/files/images/story/2026/09/25/Copenhagen--Denmark---August-3--2019-3m-.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "HUM",
"summary": "Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.",
"category": "company",
"datetime": 1790347621,
"headline": "This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday"
},
{
"id": 140701481,
"url": "https://finnhub.io/api/news?id=01e6e03b84a7b35aac28fb47af397adbda237de6cf33812e0a2da0c0696c1ae4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "IBM upgrade, SpaceX initiation among today's top calls on Wall Street",
"category": "company",
"datetime": 1790343814,
"headline": "IBM upgrade, SpaceX initiation among today's top calls on Wall Street"
},
{
"id": 142421430,
"url": "https://finnhub.io/api/news?id=eecd41dedad803ee95bc80410630c118848c067cdb6306e7be95cb266425763c",
"image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
"source": "ChartMill",
"related": "HUM",
"summary": "Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.",
"category": "company",
"datetime": 1790339700,
"headline": "Wondering what's happening in today's S&P500 pre-market session?"
},
{
"id": 142438361,
"url": "https://finnhub.io/api/news?id=59db29e229fb50824677effdce5ce61e6e93999fcf821e67c1867cf2b07cf3a2",
"image": "",
"source": "Benzinga",
"related": "HUM",
"summary": "Barclays analyst Andrew Mok upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $407 to $515.",
"category": "company",
"datetime": 1790336298,
"headline": "Barclays Upgrades Humana to Overweight, Raises Price Target to $515"
},
{
"id": 142437666,
"url": "https://finnhub.io/api/news?id=0ee6b5f40888c3b2506f45b8472989257b4ee9f302493f3db5fb118e6c7ea69a",
"image": "https://cdn.benzinga.com/files/images/story/2026/09/25/Display-Of-Stock-Market-Quotes.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "HUM",
"summary": "U.S. stocks rose Friday; Akamai jumped 8.1% on an $11.6B Anthropic cloud deal, while Atlas Energy, Almonty and others posted strong gains.",
"category": "company",
"datetime": 1790335052,
"headline": "Akamai, Atlas Energy Solutions, People And Other Big Stocks Moving Higher On Friday"
},
{
"id": 142384683,
"url": "https://finnhub.io/api/news?id=c21395e30aacf5f3bd20fbf13e9006f0d6a4e0d20793588da316f5b79e250925",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.",
"category": "company",
"datetime": 1790267681,
"headline": "What Should CVS Stock Investors Be Watching Now?"
},
{
"id": 142365220,
"url": "https://finnhub.io/api/news?id=dd32755ec590d1799b7d5ec3ad6f92a43dd03c670e0a73958df4dc85ca5cfada",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed right along with them. Yet a growing number of American households are choosing neither, opting instead for a decades-old alternative, which is not health insurance, built around monthly contributions and community values. “People are clearly paying high premiums now,” Liberty […] The post Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Pod",
"category": "company",
"datetime": 1790197600,
"headline": "Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast"
},
{
"id": 142363187,
"url": "https://finnhub.io/api/news?id=b94d47bbce0ea7953955a6a923c93c2c6a1272c92b020e9b95530b838666b05c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.",
"category": "company",
"datetime": 1790180809,
"headline": "Did UnitedHealth Name The Fix Before Its Stock Ran?"
},
{
"id": 142355707,
"url": "https://finnhub.io/api/news?id=4662ff75c5601db13998990c5ce991658817bef5e0713a0262b52a0544bdaa8b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Toronto, Ontario--(Newsfile Corp. - September 23, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (OTCQB: TMPTF) (\"TempraMed\" or the \"Company\"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce it has entered into a distribution agreement dated August 25, 2026 (the \"Distribution Agreement\") with CenterWell Pharmacy, Inc. (\"CenterWell\") the pharmacy services brand of Humana Inc, a major U.S. health...",
"category": "company",
"datetime": 1790147100,
"headline": "TempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana"
},
{
"id": 142342070,
"url": "https://finnhub.io/api/news?id=34b69edf2a74f0cb424507a082f3bdd474474b0b9314bc154e1fc4d76ca78ba1",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.",
"category": "company",
"datetime": 1790100599,
"headline": "Can UNH Stock Keep Growing Earnings While Its Sales Stall?"
},
{
"id": 142315098,
"url": "https://finnhub.io/api/news?id=8dc65a87533f54ae58d8fefcc45dfb7d67a5bd4c66cf394114b9b5116ce49f36",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "HUM",
"summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.",
"category": "company",
"datetime": 1790017501,
"headline": "Monday's session: top gainers and losers in the S&P500 index"
},
{
"id": 142259580,
"url": "https://finnhub.io/api/news?id=89921bae1997322422e9319a30a5dd8a72284387734060c40f8b39cb717d64b1",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.",
"category": "company",
"datetime": 1789742520,
"headline": "Can Cigna's AI Push Help Rein In Rising Healthcare Costs?"
},
{
"id": 142253967,
"url": "https://finnhub.io/api/news?id=cc96e85bcbd3f911ee04bc5faedce46fa69ce08f2304cc6523cc0ba700260543",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.",
"category": "company",
"datetime": 1789733701,
"headline": "Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?"
},
{
"id": 142253117,
"url": "https://finnhub.io/api/news?id=e11028fe46d2f48c6ef48e72b060b54606b0ee35c8994be445e30b364af77ec5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
"category": "company",
"datetime": 1789727560,
"headline": "2 Unpopular Stocks That Should Get More Attention and 1 We Question"
},
{
"id": 142231473,
"url": "https://finnhub.io/api/news?id=30df880a56c5295e42ccef56f6654b312adc745dad00fe838d58243ab584a373",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.",
"category": "company",
"datetime": 1789659000,
"headline": "Can Centene Sustain Its Turnaround Amid Membership Pressure?"
},
{
"id": 142223782,
"url": "https://finnhub.io/api/news?id=d822589fb641971cc9ec09849131d713771573965270318e8d0134de30ce5826",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "LOUISVILLE, Ky., September 17, 2026--A new research study finds an association between pharmacy care coordination services and improved health outcomes for cancer patients.",
"category": "company",
"datetime": 1789646460,
"headline": "New Humana research finds association between pharmacy care coordination services and improved health outcomes for cancer patients"
},
{
"id": 142213885,
"url": "https://finnhub.io/api/news?id=4c0c1b40c39b4cd3cde08377f58d6a5a0e9a8ef017f648fcbdfe8c5296450c0c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...",
"category": "company",
"datetime": 1789629223,
"headline": "3 Health Care Stocks Built For Higher Rates"
},
{
"id": 142231472,
"url": "https://finnhub.io/api/news?id=4dc012de61c556e431b75d6fea82414e40a3feefd245b616e30e4e566497774f",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Americans on Medicare Advantage plans may soon get a breakup letter in the mail: Your insurer is canceling your plan. Humana and other Advantage insurers are sending letters this fall to plan members about 2027 coverage. As insurers look to cut costs, some are discontinuing their Advantage plans.",
"category": "company",
"datetime": 1789624800,
"headline": "Losing Your Medicare Plan? There’s a Silver Lining."
},
{
"id": 142198233,
"url": "https://finnhub.io/api/news?id=62893c934108390cb4e84f708579862ec5e7b3b4291db08db0f2465e4946203f",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.",
"category": "company",
"datetime": 1789579013,
"headline": "The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet"
},
{
"id": 142195393,
"url": "https://finnhub.io/api/news?id=3b6bdf092a40c927edad0623e8edc6e5b71ea42aeeb8a305c4b1d7ce904318a9",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "LOUISVILLE, Ky., September 16, 2026--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company’s annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200 nonprofit organizations, and positively impacted 2.25 million lives and community members through volunteer projects focused on food security, neighborhood revitalization, environmental stewardship and soci",
"category": "company",
"datetime": 1789560000,
"headline": "Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide"
},
{
"id": 142160447,
"url": "https://finnhub.io/api/news?id=4b9006c710441c6abe75ec2c80a73863bb98fbc34d77513d5450c84b1e5fbe3b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "DUBLIN, Ohio, September 15, 2026--Quantum Health, the industry-leading healthcare navigation company, today announced the appointment of Susan Mani, M.D., as Chief Medical Officer. Dr. Mani will shape Quantum Health's clinical strategy, working to improve healthcare experiences, results and affordability for members and clients.",
"category": "company",
"datetime": 1789475400,
"headline": "Quantum Health Names Dr. Susan Mani as Chief Medical Officer"
},
{
"id": 142160446,
"url": "https://finnhub.io/api/news?id=d67ac2dbf48f6d0dd329d1ab5d26bad186d15e36a2775d4b1c565d6f5111cfbb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "NEW YORK, September 15, 2026--CalmiGo, developer of the first and only mental health platform that provides immediate relief and long-term care to users suffering from anxiety, PTSD, and panic attacks, announces today that its platform has been selected for CMS’s ACCESS program, offering technology-supported chronic care for behavioral health conditions. Medicare serves over 70 million patients and created the ACCESS program to expand access to technology-supported chronic care. Fourteen additio",
"category": "company",
"datetime": 1789470000,
"headline": "CalmiGo Selected for CMS’s ACCESS Program to Provide Technology-Supported Chronic Care for Behavioral Health Conditions"
},
{
"id": 142158658,
"url": "https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...",
"category": "company",
"datetime": 1789463559,
"headline": "Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"
},
{
"id": 142148504,
"url": "https://finnhub.io/api/news?id=109a37c3b4773b9929db5c05c3b3c1772031edcc000e87fd9e98d6856be6a6c6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana listed Counterpart Health among the vendors for its provider-performance and quality programs.",
"category": "company",
"datetime": 1789438099,
"headline": "CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences"
},
{
"id": 142141425,
"url": "https://finnhub.io/api/news?id=1319d644a68d1a16e7a0fdb153103e0f98cb9c4ea9eee6a94f946c434dcaf49d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.",
"category": "company",
"datetime": 1789420257,
"headline": "CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?"
},
{
"id": 142141467,
"url": "https://finnhub.io/api/news?id=40c7ec190f17456e6d4cedac5eaa7a53021f0b8cfbc64b185ac0b994c06ac9e3",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.",
"category": "company",
"datetime": 1789414884,
"headline": "Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?"
},
{
"id": 142088659,
"url": "https://finnhub.io/api/news?id=bdc2f3449be06089f2a7a0fff4946e8fcf53edb531611c3d7f202790ddc443c0",
"image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "HUM",
"summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
"category": "company",
"datetime": 1789133712,
"headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
},
{
"id": 142064801,
"url": "https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.",
"category": "company",
"datetime": 1789069012,
"headline": "Should You Buy Elevance Health Stock For The Margin It Lost?"
},
{
"id": 142063328,
"url": "https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.",
"category": "company",
"datetime": 1789061100,
"headline": "UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"
},
{
"id": 142062099,
"url": "https://finnhub.io/api/news?id=5ef3409d6896f45882c982d485a19acdb3f58328a0fe0fbafc647d8ddf483972",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "LOUISVILLE, Ky., September 10, 2026--A new peer-reviewed study from Humana Healthcare Research published in Health Affairs Scholar found that Medicare Advantage beneficiaries who used an integrated specialty pharmacy, which coordinates pharmacy services with a beneficiary’s health plan, experienced faster access to specialty medications and lower out-of-pocket pharmacy costs compared with beneficiaries using non-integrated specialty pharmacies. The research suggests that greater coordination bet",
"category": "company",
"datetime": 1789048800,
"headline": "New Study Links Integrated Specialty Pharmacy Care to Faster Access and Lower Costs"
},
{
"id": 142060930,
"url": "https://finnhub.io/api/news?id=2e74443f51fae12373b55f78e2aa434fd344482bd09547fc850da95b2f997f90",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.",
"category": "company",
"datetime": 1789045980,
"headline": "BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?"
},
{
"id": 142029915,
"url": "https://finnhub.io/api/news?id=a3f21a82f91c178faa0f4bc8487cc5be3663f08d7ba39cae1a62306d768a3c3e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train […]",
"category": "company",
"datetime": 1788986449,
"headline": "Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?"
},
{
"id": 142028659,
"url": "https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.",
"category": "company",
"datetime": 1788982210,
"headline": "Why Is UNH Stock Trading At A Premium With The Slowest Growth?"
},
{
"id": 142025948,
"url": "https://finnhub.io/api/news?id=40dfd9205ae43e624ebad1b59d50330d3017274c720b1d7abe70d6b8ef8c5fe4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UNH is investing nearly $1.5B in AI to expand Optum Insight's software offerings, boost efficiency and unlock new growth opportunities.",
"category": "company",
"datetime": 1788967800,
"headline": "Can UnitedHealth's AI Strategy Strengthen Optum Insight's Growth?"
},
{
"id": 142029916,
"url": "https://finnhub.io/api/news?id=3966d13a5e361af4bd335e93fb8462237491ffa516fecce2986dba7d99b8387f",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana has outperformed the broader Dow Jones index over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.",
"category": "company",
"datetime": 1788965754,
"headline": "Is Humana Stock Outperforming the Dow?"
},
{
"id": 142025949,
"url": "https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.",
"category": "company",
"datetime": 1788964814,
"headline": "UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"
},
{
"id": 142024396,
"url": "https://finnhub.io/api/news?id=fee7ff8411d4d6ec06d6d4910d7f911dd35d3fd361ea815c362df264666f9d36",
"image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
"source": "ChartMill",
"related": "HUM",
"summary": "Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
"category": "company",
"datetime": 1788957301,
"headline": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session."
},
{
"id": 141546908,
"url": "https://finnhub.io/api/news?id=8e571c6258a78e295e3d3b62ceae232f24f7212af2894b0de642b2676a6a05ba",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.",
"category": "company",
"datetime": 1788642735,
"headline": "Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2."
},
{
"id": 141446662,
"url": "https://finnhub.io/api/news?id=5d83f5780b6dfb902bdb5621ef012795ad52a453dd0b77ba71da028ec44295d8",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.",
"category": "company",
"datetime": 1788537840,
"headline": "UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?"
},
{
"id": 141423004,
"url": "https://finnhub.io/api/news?id=b47380288cfd261087fd1c7cf10b6f8585c62315443d5115620975ccc52ecc91",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.",
"category": "company",
"datetime": 1788522610,
"headline": "1 High-Flying Stock for Long-Term Investors and 2 Facing Headwinds"
},
{
"id": 141423002,
"url": "https://finnhub.io/api/news?id=5a680d055ddeb06d8e5ed20a8ec2f72d7a90a006a3aa38bc3fb209ea607b65ea",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "DaVita (DVA) is back in focus after two meaningful developments. The company expanded its value based care partnership with Humana for chronic kidney disease patients and agreed to a US$15 million settlement related to a prior data breach. Investors have been reacting to this mix of partnership news and legal resolution with a share price that is still up 58.64% year to date, despite a 30 day share price return of down 20.32%. The 3 year total shareholder return of 90.54% points to momentum...",
"category": "company",
"datetime": 1788520425,
"headline": "DaVita (DVA) Has Investors Asking A Fresh Question"
},
{
"id": 141403928,
"url": "https://finnhub.io/api/news?id=de3b755458a0692786e98c8730379abffa2f396e858720998b049556eefd1eec",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana's non-renewal letters are already in the mail, and the deadline to act is closer than most affected members realize. Missing it by even one day changes what coverage options remain available and how much they cost.",
"category": "company",
"datetime": 1788463703,
"headline": "If Your Advantage Plan Ends December 31 and You Do Nothing, You Wake Up January 1 in Original Medicare With No Drug Coverage and No Medigap."
},
{
"id": 141402794,
"url": "https://finnhub.io/api/news?id=c5b2226aff37f7fdea42ffc0a3e08c7d47d198279f6393e69e1234a596a2456a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.",
"category": "company",
"datetime": 1788456945,
"headline": "UnitedHealth Stock Recovered Before Its Margins Did"
},
{
"id": 141400357,
"url": "https://finnhub.io/api/news?id=19b31dad684a09c10510e4d143d2601be86618c98904802e5c585553b6fe199e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.",
"category": "company",
"datetime": 1788446735,
"headline": "CVS Stock Has Left Its Peers Behind. Or Has It?"
},
{
"id": 141400598,
"url": "https://finnhub.io/api/news?id=3a6679a4fcbe4b0468c5eb51b8e05f0b6aa44ae84a4b8c4a728e14059920ae68",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "A retirement community's top health provider quietly told the government it had been overbilling Medicare for years, then filed for bankruptcy before the consequences arrived. What happened next reshaped who owns the clinics, who absorbs the loss, and what federal prosecutors are targeting next.",
"category": "company",
"datetime": 1788446287,
"headline": "For 4 Years, The Villages’ Top Health Provider Allegedly Filed False Medicare Codes. The Bill Just Came Due: $541.5 Million."
},
{
"id": 141400599,
"url": "https://finnhub.io/api/news?id=9d90d4e5138ac8a98cf320fac328abc928691d6bcb98f4bb3028b0f9bb6de468",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]",
"category": "company",
"datetime": 1788446067,
"headline": "Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?"
},
{
"id": 141398394,
"url": "https://finnhub.io/api/news?id=5ecbb193cb85190f3f48ea058a6967f06b7f0314381e2841cd1b73bdd1c3bf22",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "LOUISVILLE, Ky., September 03, 2026--Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition",
"category": "company",
"datetime": 1788440400,
"headline": "Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition"
},
{
"id": 141398395,
"url": "https://finnhub.io/api/news?id=52197c23d741cca5892b2746c42c80631fda597e5439d0029571d1b451bb190a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "By endorsing Mark Cuban‘s proposals to make prescription drug pricing more transparent, Bill Ackman shifted the conversation from healthcare policy to something investors care about just as much: whether the traditional pharmacy benefit manager (PBM) model is facing a growing...",
"category": "company",
"datetime": 1788438664,
"headline": "Bill Ackman Backs Mark Cuban's Drug Pricing Model: These Healthcare Stocks Could Win—Or Lose"
},
{
"id": 141379619,
"url": "https://finnhub.io/api/news?id=955bd6154f46d896e37490a441a69875797708f3521c372fac6045a27e93d5e9",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Thyme Care, the nationally recognized oncology company, today announced a new Series E financing round of over $125M. Morgan Health led the round, with participation from strategic healthcare investors Humana and CVS Health Ventures, as well as institutional investors AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.",
"category": "company",
"datetime": 1788364800,
"headline": "Thyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology Ecosystem"
},
{
"id": 141379150,
"url": "https://finnhub.io/api/news?id=fac6b53077cb17d7af20e819aacca07cf62593653b986be157b110f4bed8e7fd",
"image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "HUM",
"summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
"category": "company",
"datetime": 1788356125,
"headline": "10 Health Care Stocks Whale Activity In Today’s Session"
},
{
"id": 141376490,
"url": "https://finnhub.io/api/news?id=7089e5e97cc78f2f8e46f615a87ce7a52143f01f13c4c4c92cd02ceb8756bbeb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "LOUISVILLE, Ky., September 02, 2026--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026.",
"category": "company",
"datetime": 1788348600,
"headline": "Humana Board Declares Payment of Quarterly Dividend to Stockholders"
},
{
"id": 141379621,
"url": "https://finnhub.io/api/news?id=a6d938412017df82b4c3588f20f001f57b3cf997f8e58993d6676030daa79f8a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Daniel Chojnowski, JHHP’s current CFO, will provide stability so that the Baltimore-area insurer can recruit full-time for its next chief executive, the company said.",
"category": "company",
"datetime": 1788346743,
"headline": "Johns Hopkins Health Plans taps interim CEO as it searches for successor"
},
{
"id": 141363990,
"url": "https://finnhub.io/api/news?id=d8d5bb41fbb758c304ca112e2b71c45105d7af2e7520ac3aa026b2d9a7a21438",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana (HUM) has drawn fresh attention after announcing that Shantanu Nundy, M.D., will become Chief Medical Officer on August 31, 2026, in a move that foregrounds technology, AI and clinical leadership. Humana’s appointment of a technology focused Chief Medical Officer comes as the stock trades at US$383.23. The share price return is up 5.32% over 30 days and 19.43% over 90 days, while the year-to-date share price return of 44.90% contrasts with a 3-year total shareholder return that has...",
"category": "company",
"datetime": 1788271598,
"headline": "Humana (HUM) Names New Medical Chief On AI Push As Valuation Debate Builds"
},
{
"id": 141363991,
"url": "https://finnhub.io/api/news?id=7c73358c9d2b5f1658b408c9e638de39c0052960157b94807434371d0c767764",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "LOUISVILLE, Ky., September 01, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship Program.",
"category": "company",
"datetime": 1788267600,
"headline": "Humana Foundation Names 2026 Scholarship Recipients"
},
{
"id": 141369187,
"url": "https://finnhub.io/api/news?id=efc3da274f0ad5bd69acce8293e14118c2980c701e25a977ad4af86808ec1c51",
"image": "https://cdn.benzinga.com/files/images/story/2026/09/01/New-York-Ny-Usa-march-21--2024-The-New-Y.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "HUM",
"summary": "The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.",
"category": "company",
"datetime": 1788267096,
"headline": "Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today"
},
{
"id": 141371368,
"url": "https://finnhub.io/api/news?id=44123b131d75bfb6f1388867c0d31be1514fc4941a8c48213c2ed05025802002",
"image": "",
"source": "Benzinga",
"related": "HUM",
"summary": "https://www.sec.gov/ix?doc=/Archives/edgar/data/0000049071/000004907126000052/hum-20260901.htm",
"category": "company",
"datetime": 1788248223,
"headline": "Humana Reiterates FY26 Adjusted EPS Outlook Of At Least $9"
},
{
"id": 141361168,
"url": "https://finnhub.io/api/news?id=1cbf7f516ca93aacdc4e94985c792cd793c6948f29279ace82eac658358e283e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.",
"category": "company",
"datetime": 1788204328,
"headline": "UNH Stock Gets Cheaper Only If The Margins Come Back"
},
{
"id": 141363992,
"url": "https://finnhub.io/api/news?id=ffde99a5e0fe49fb4a8d5dbbe5de9c2ce50d65cce5f98ee9d00646e9a0845b91",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "A non-renewal notice from Humana can feel like bad news, but buried inside federal Medicare rules is a protection that most long-time Advantage members have no idea they still qualify for.",
"category": "company",
"datetime": 1788107422,
"headline": "Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October."
},
{
"id": 141348696,
"url": "https://finnhub.io/api/news?id=e21e41f3ee9a082fe4b89d56b633a2d96bf0fff4264582b1399beef45b1bd20e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Its market-shock drawdowns have been ordinary in depth, and some of its longest waits back to the old high came after falls the index barely noticed.",
"category": "company",
"datetime": 1787943961,
"headline": "Is CVS Stock Set for a Rebound?"
},
{
"id": 141364000,
"url": "https://finnhub.io/api/news?id=37a72908f114871f1a4dad46f9fc801a4f8980f63b77c0174b1008921028a865",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.",
"category": "company",
"datetime": 1787935140,
"headline": "CVRx Secures Devoted Health Coverage for Barostim Therapy"
},
{
"id": 141363993,
"url": "https://finnhub.io/api/news?id=e9fd48aaac9ac9421f4402b744ac94953fe99973db974354eaa0fb5a8da7dbc9",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1787934616,
"headline": "Why Is Humana (HUM) Up 7.1% Since Last Earnings Report?"
},
{
"id": 141348699,
"url": "https://finnhub.io/api/news?id=7b9aaf0f06e7f13118a9e7ec9ec53b07edb5eb36492e127cd742bf487132234d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HUM",
"summary": "The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.",
"category": "company",
"datetime": 1787876791,
"headline": "Can a $68 Billion Payout Save UNH Stock?"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 7,
"negative_hits": 0,
"positive_hits": 2,
"recomputed_at_score": true,
"sentiment_score_raw": 0.7,
"source_article_count": 70,
"discarded_article_count": 63
},
"sentimentPoints": 4
}
},
"技術信號": {
"max": 30,
"raw": 19.9,
"grade": "一般",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 3,
"vcpPoints": 1,
"macdPoints": 0.8,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 1,
"vcp_reason": "跌縮量(近10日5日);站上MA50;Ready=N;Confirm=N",
"vcp_metrics": {
"up_days": 3,
"vol_ref": 943066.6666666666,
"down_days": 6,
"vcp_ready": false,
"above_ma50": true,
"avg_vol_10": 929320,
"avg_vol_20": 917980,
"avg_vol_30": 943066.6666666666,
"range_pct_10": 0.11720652167985633,
"range_pct_20": 0.12776116723446765,
"range_pct_30": 0.12776116723446765,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": false,
"down_shrink_ok": true,
"up_expand_days": 1,
"breakout_20d_ok": false,
"vol_ratio_10_30": 0.9854234412554786,
"dist_to_20d_high": 0.05247996285448973,
"down_shrink_days": 5,
"breakout_level_20d": 419.97,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 0.9173876868607391
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": false
},
"kdjAdxPoints": 0.7,
"rsiKdjPoints": 2.4,
"volumeWeight": 2,
"maCrossPoints": 2.4,
"shortRsiPoints": 1,
"shortMacdPoints": 0.4,
"volConfirmPoints": 1,
"volumePointsTechnical": 1.2
}
},
"風險管理": {
"max": 10,
"grade": "較差",
"items": {
"position": {
"score": 1.3,
"details": {
"atrPct": 3.522504046503255,
"turnoverUsdM": 771.387285615,
"liquidityPoints": 0.6,
"volatilityPoints": 0.7
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.HUM",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 369.8958,
"strength_details": {
"ma_score": 2,
"atr_score": 1,
"rsi_score": 1,
"macd_score": 1,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1,
"stop_loss_percent": 7,
"take_profit_price": 418.8622,
"target_multiplier": 1.6,
"technical_strength": 1.4,
"take_profit_percent": 5.3
},
"positionPoints": 1.3,
"stopLossPoints": 1.2,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 7.04500809300651,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 85.71,
"atr": {
"atr": 14.0171,
"rule": "ATR / current price; lower volatility scores higher",
"score": 4,
"atr_pct": 3.52
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "平衡",
"score": 6,
"value": 40.3
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.1057
},
"kdj": {
"d": 24.06,
"j": 50.42,
"k": 32.84,
"rule": "Cursor_18.24 K/D cross",
"score": 4,
"signal": "金叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "弱流入",
"score": 4,
"value": 45.03
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 6,
"trend": "有流入",
"value": 7742000,
"recentSlope": 79420,
"previousSlope": 184450
},
"rsi": 47.79,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 10,
"trend": "上升",
"value": 369.13,
"position": "SAR由上轉下+趨勢強",
"distancePct": 7.24,
"previousTrend": "下降"
},
"ma50": 386.7364,
"macd": {
"macd": -1.5382989684813992,
"trend": "看跌",
"signal": -0.14559927474376366,
"histogram": -1.3926996937376357
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 6,
"value": 392.8659,
"position": "連續1-2日>VWAP",
"consecutiveAbove": 1
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "有量",
"ratio": 2,
"score": 6,
"avgVolume": 969940,
"currentVolume": 1938500
},
"derived": {
"ma20": 392.4515,
"ma50": 386.7364,
"prevClose": 380.32,
"avgVolume10": 1054760,
"avgVolume20": 969940,
"changePercent": 4.63,
"avgVolumeForScore": 969940
},
"ma_cross": {
"ma20": 392.4515,
"ma50": 386.7364,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "接近",
"score": 6,
"prevMa20": 392.1865,
"prevMa50": 386.5074,
"spreadPct": 1.48,
"isVolumeBreakout": true
},
"bollinger": {
"lower": 369.988,
"upper": 414.915,
"position": "上半部"
},
"rsi_short": 66.02,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 2
}
}
}
Raw metrics JSON
{
"close": 397.93,
"volume": 1938500,
"changePercent": 4.63
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.